Rafael Sanchez‐Salas

Institute Mutualiste Montsouris

Papers

6

Total Citations

257

H-Index

6

About

Rafael Sanchez‐Salas is a leading figure in urologic oncology, specializing in minimally invasive surgery for prostate and kidney cancers. His work has significantly advanced the understanding and practice of robotic-assisted procedures, particularly in radical prostatectomy and nephron-sparing surgery. A key contribution is his landmark multinational study comparing 22,393 open, laparoscopic, and robot-assisted radical prostatectomies, which demonstrated superior positive surgical margin rates for robotic approaches—a finding cited over 150 times and widely adopted in clinical guidelines. He has also pioneered techniques to achieve "trifecta" outcomes (cancer control, renal function preservation, and complication avoidance) in partial nephrectomy, transitioning from laparoscopic to robotic platforms. Notably, his systematic review on aspirin suspension before robotic prostatectomy provided critical safety data for perioperative management. With a focus on optimizing functional and oncologic outcomes, Sanchez‐Salas continues to refine surgical protocols, as seen in his recent work on early postoperative kidney function metrics. His research, spanning high-volume centers and international collaborations, has shaped modern urologic practice, making him a respected authority in robotic surgery and evidence-based perioperative care.

Research Focus

Key Achievements

6
H-Index
6
Papers
257
Total Citations
43
Avg Citations/Paper
🏆 Most Cited Paper
A Multinational, Multi-institutional Study Comparing Positive Surgical Margin Rates Among 22 393 Open, Laparoscopic, and Robot-assisted Radical Prostatectomy Patients
151 citations · 2013
📈 Most Prolific Year: 2021 (2 Papers)
🤝 Key Collaborators: 67
🏛 Institutions: Institute Mutualiste Montsouris

Top Papers

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 14 days ago